Clinical Pharmacology of Direct and Indirect Factor Xa Inhibitors

Author： Rupprecht Hans-Juergen Blank Ralf

ISSN： 0012-6667

Source： Drugs, Vol.70, Iss.16, 2010-11, pp. : 2153-2170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent advances in clinical trials of the direct and indirect selective Factor Xa inhibitors

By Porcari A.R. Chi L. Leadley R.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. : 1595-1600

Informa Healthcare

Access to resources Recommend Favorite

Clinical and Experimental Experience with Factor Xa Inhibitors

By Juan F. Viles-Gonzalez Juan Gaztanaga Urooj M. Zafar Valentin Fuster Juan J. Badimon

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 6, 2004-01 ,pp. : 379-384

Adis International

Access to resources Recommend Favorite

Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development

By Eriksson Bengt I.

Clinical Pharmacokinetics, Vol. 48, Iss. 1, 2009-01 ,pp. : 1-22

Adis International

Access to resources Recommend Favorite

Recent Advances in the Discovery and Development of Direct Coagulation Factor Xa Inhibitors

Current Pharmaceutical Design, Vol. 9, Iss. 28, 2003-11 ,pp. : 2337-2347

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Direct Factor IIa and Xa Inhibitors: Mechanisms of Action and Preclinical Studies

Current Clinical Pharmacology, Vol. 7, Iss. 3, 2012-01 ,pp. : 149-165

Bentham Science Publishers

Access to resources Recommend Favorite